• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
S-(−)-Schisandrin B

S-(−)-Schisandrin B

Product ID S0831
Cas No. 61281-37-6
Purity ≥98%
Product Unit SizeCostQuantityStock
5 mg $201.40 In stock
10 mg $330.00 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Schisandrin B is found in Schisandra; it exhibits anti-fibrotic, anti-inflammatory, cardioprotective, hepatoprotective, neuroprotective, and anti-metastatic activities. In vitro, schisandrin B decreases TGF-β1-induced myosin light chain phosphorylation and Smad signaling, preventing stress fiber formation. In animal models of myocardial infarction, schisandrin B downregulates expression of pro-inflammatory cytokines and inhibits myocardial apoptosis, decreasing infarct size and improving heart function and survival rates. Schisandrin B also increases expression of HSP27 and HSP70, inhibiting acetaminophen-induced liver injury and hepatic necrosis. In animal models of cerebral ischemia/reperfusion, this compound decreases expression of IL-1β and TNF-α and prevents degradation of matrix metalloproteinases 2 and 9 (MMP2/9), decreasing infarct volume. Additionally, schisandrin B inhibits invasion of breast cancer cells by suppressing the epithelial to mesenchymal transition (EMT), increasing survival rates in vivo.

Product Info

Cas No.

61281-37-6

Purity

≥98%

Formula

C23H28O6

Formula Wt.

400.47

Chemical Name

Benzo(3,4)cycloocta(1,2-f)(1,3)benzodioxole, 5,6,7,8- tetrahydro-1,2,3,13-tetramethoxy-6,7-dimethyl-, stereoisomer

IUPAC Name

3,4,5,19-tetramethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.02,7.014,18]nonadeca-1(19),2,4,6,12,14(18)-hexaene

Synonym

γ-Schisandrin, S(-) Wuweizisu B, S(-) Schizandrin B

Melting Point

100-102°C

Appearance

White Crystal Powder

Shipping and Storage

Store Temp

4°C

Ship Temp

Ambient

Downloads

MSDS

S0831 MSDS PDF

Info Sheet

S0831 Info Sheet PDF

References

Chun JN, Kim SY, Park EJ, et al. Schisandrin B suppresses TGFβ1-induced stress fiber formation by inhibiting myosin light chain phosphorylation. J Ethnopharmacol. 2014 Mar 14;152(2):364-71. PMID: 24486209.

Li L, Zhang T, Zhou L, et al. Schisandrin B attenuates acetaminophen-induced hepatic injury through heat-shock protein 27 and 70 in mice. J Gastroenterol Hepatol. 2014 Mar;29(3):640-7. PMID: 24219791.

Chen P, Pang S, Yang N, et al. Beneficial effects of schisandrin B on the cardiac function in mice model of myocardial infarction. PLoS One. 2013 Nov 8;8(11):e79418. PMID: 24260217.

Lee TH, Jung CH, Lee DH. Neuroprotective effects of Schisandrin B against transient focal cerebral ischemia in Sprague-Dawley rats. Food Chem Toxicol. 2012 Dec;50(12):4239-45. PMID: 22960133.

Liu Z, Zhang B, Liu K, et al. Schisandrin B attenuates cancer invasion and metastasis via inhibiting epithelial-mesenchymal transition. PLoS One. 2012;7(7):e40480. PMID: 22848381.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • G5322

    GNF-5

    Abl inhibitor.

    ≥99%
  • A1592

    ADX-47273

    mGluR5 positive modulator.

    ≥98%
  • T7133

    Trimetazidine Dihydrochloride

    Long-chain 3-ketoacyl-CoA thiolase inhibitor, p...

    ≥99%
  • E6470

    Eprinomectin

    Semi-synthetic avermectin; GABA potentiator.

    ≥45%
  • B1654

    Benzyl Selenocyanate

    Organoselenium compound found in selenium-enric...

    ≥98%
  • D5692

    Doxifluridine

    5-Fluorouracil prodrug, pyrimidine nucleoside a...

    ≥98%
  • C9879

    Cytochalasin B

    Mycotoxin produced by Aspergillus; actin polyme...

    ≥98%
  • A2054

    Aflatoxin M2

    Mycotoxin produced by species of Aspergillus; D...

    ≥98%
  • E5217

    β-Endorphin, human

    Endogenous opioid peptide; μOR agonist.

    ≥95%
  • D3428

    Dihydrochelerythrine

    Benzophenanthridine alkaloid found in Garcinia....

    ≥98%
  • H9662

    Hypocrellin B

    Induces DNA strand breakage.

    ≥98%
  • H1658

    Heparin Sodium

    Endogenous glycosaminoglycan that is produced b...

    Bioassay ≥140 U/mg
  • R2710

    Recombinant Multi-epitope Chimeric HCV Antigen

    Recombinant Multi-epitope Chimeric HCV antigen....

    ≥95%
  • C8112

    CUDC-907

    PI3K and HDAC inhibitor.

    ≥98%
  • M0374

    Masitinib

    PDGFR and c-Kit inhibitor.

    ≥99%
  • P6802

    Pranoprofen

    NSAID; COX-1/2 inhibitor.

    ≥98%
  • B1992

    Bexarotene

    RXR agonist.

    ≥98%
  • E5576

    Entecavir

    Nucleoside (deoxyguanosine) analog; DNA chain t...

    ≥97%
  • T6902

    Tranilast

    Mast cell stabilizer; TRPV2 antagonist, PDGFR i...

    ≥98%
  • G7340

    GSK-126

    EZH2 HMT inhibitor.

    ≥98%, ≥99%ee

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only